Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Clopidogrel in Medically Managed ACS
NCT00699998Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 53
01
Overview
A Phase 3 trial of prasugrel in acute coronary syndrome (ACS), unstable angina, non-ST elevation myocardial infarction (NSTEMI), sponsored by Eli Lilly and Company. Started Jun 2008; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)unstable anginanon-ST elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00699998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699998.